Hochschulschrift
LPPR5 expression in glioma affects growth, vascular architecture, and sunitinib resistance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
67 Seiten
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Literaturverzeichnis: Seite 42-48
Enthält 1 Sonderabdruck
Johann Wolfgang Goethe-Universität Frankfurt am Main, Dissertation, 2023
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (when)
-
2022
- Creator
- Contributor
- Table of contents
-
LPPR5 expression in glioma affects growth, vascular architecture, and sunitinib resistance Lena Stange, Kristin Elizabeth Lucia, Adnan Ghori, Peter Vajkoczy, Marcus Czabanka and Thomas Broggini
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 2:14 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2022
Other Objects (12)
LPPR5 Expression in Glioma Affects Growth, Vascular Architecture, and Sunitinib Resistance
Endothelial ephrinB2 regulates Sunitinib therapy response in murine glioma
Calcium affects on vascular endpoints
Sunitinib-Sorafenib- versus Sunitinib-Everolimus-Sequenztherapie beim Nierenzellkarzinom
Ipotiroidismo indotto da sunitinib
Sunitinib-Induced Acute Liver Failure
Sunitinib nei feocromocitomi e paragangliomi
The dystroglycan receptor maintains glioma stem cells in the vascular niche
Scan speed affects quantitative optical coherence tomography angiography vascular metrics
Chromosomal instability induced by increased BIRC5/Survivin levels affects tumourigenicity of glioma cells
Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells
Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment
LPPR5 Expression in Glioma Affects Growth, Vascular Architecture, and Sunitinib Resistance
Endothelial ephrinB2 regulates Sunitinib therapy response in murine glioma
Calcium affects on vascular endpoints
Sunitinib-Sorafenib- versus Sunitinib-Everolimus-Sequenztherapie beim Nierenzellkarzinom
Ipotiroidismo indotto da sunitinib
Sunitinib-Induced Acute Liver Failure
Sunitinib nei feocromocitomi e paragangliomi
The dystroglycan receptor maintains glioma stem cells in the vascular niche
Scan speed affects quantitative optical coherence tomography angiography vascular metrics
Chromosomal instability induced by increased BIRC5/Survivin levels affects tumourigenicity of glioma cells
Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells
Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment
LPPR5 Expression in Glioma Affects Growth, Vascular Architecture, and Sunitinib Resistance
Endothelial ephrinB2 regulates Sunitinib therapy response in murine glioma
Calcium affects on vascular endpoints
Sunitinib-Sorafenib- versus Sunitinib-Everolimus-Sequenztherapie beim Nierenzellkarzinom
Ipotiroidismo indotto da sunitinib
Sunitinib-Induced Acute Liver Failure
Sunitinib nei feocromocitomi e paragangliomi
The dystroglycan receptor maintains glioma stem cells in the vascular niche
Scan speed affects quantitative optical coherence tomography angiography vascular metrics
Chromosomal instability induced by increased BIRC5/Survivin levels affects tumourigenicity of glioma cells
Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells